Registry of Lobbyists

Advanced Registry Search Results

Search Criteria

Search for merck canada in registrations and monthly communication reports

Refine registrations results by

Status Type Subject matter Government institutions

If you would like to view a summary of the last 12 months for a lobbying activity, use the 12-Month Lobbying Activity Search

Registration (111)
Results: 1-50 | Export
  1. Merck Canada
    Type: Consultant
    Lobbyist: Francois de Le Rue, Teneo
    Registration: 2 of 2 (2023-11-30 to present)
    Posted: 2023-11-30
    Subject matter details: 1
    Government institutions: 3
    Communication techniques: 2
    Government funding: No
  2. Canadian Antimicrobial Innovation Coalition
    Type: Consultant
    Lobbyist: Joanna Carey, Magnet Strategy Group
    Registration: 5 of 5 (2023-10-01 to present)
    Posted: 2023-11-09
    Subject matter details: 2
    Government institutions: 8
    Communication techniques: 2
    Government funding: No
  3. Merck Canada Inc.
    Type: Consultant
    Lobbyist: Joanna Carey, Magnet Strategy Group
    Registration: 5 of 5 (2023-07-17 to present)
    Posted: 2023-07-17
    Subject matter details: 2
    Government institutions: 8
    Communication techniques: 2
    Government funding: No
  4. Merck Canada Inc.
    Type: Consultant
    Lobbyist: Danielle Peters, Magnet Strategy Group
    Registration: 7 of 7 (2023-01-02 to present)
    Posted: 2023-03-20
    Subject matter details: 2
    Government institutions: 6
    Communication techniques: 2
    Government funding: No
  5. Canadian Antimicrobial Innovation Coalition
    Type: Consultant
    Lobbyist: Joanna Carey, Magnet Strategy Group
    Registration: 4 of 5 (2022-12-22 to 2023-10-01)
    Posted: 2022-12-22
    Subject matter details: 2
    Government institutions: 7
    Communication techniques: 2
    Government funding: No
  6. Canadian Antimicrobial Innovation Coalition
    Type: Consultant
    Lobbyist: Danielle Peters, Magnet Strategy Group
    Registration: 3 of 3 (2022-11-01 to present)
    Posted: 2022-11-15
    Subject matter details: 1
    Government institutions: 6
    Communication techniques: 2
    Government funding: No
  7. Canadian Antimicrobial Innovation Coalition
    Type: Consultant
    Lobbyist: Danielle Peters, Magnet Strategy Group
    Registration: 2 of 3 (2022-04-01 to 2022-11-01)
    Posted: 2022-05-02
    Subject matter details: 1
    Government institutions: 6
    Communication techniques: 2
    Government funding: No
  8. Merck Canada Inc.
    Type: Consultant
    Lobbyist: Joanna Carey, Magnet Strategy Group
    Registration: 4 of 5 (2022-03-28 to 2023-07-17)
    Posted: 2022-04-19
    Subject matter details: 2
    Government institutions: 8
    Communication techniques: 2
    Government funding: No
  9. Merck Canada
    Type: Consultant
    Lobbyist: Francois de Le Rue, Teneo
    Registration: 1 of 2 (2022-03-17 to 2023-11-30)
    Posted: 2022-03-17
    Subject matter details: 1
    Government institutions: 3
    Communication techniques: 2
    Government funding: No
  10. Merck Canada Inc.
    Type: Consultant
    Lobbyist: Joanna Carey, Magnet Strategy Group
    Registration: 3 of 5 (2022-01-06 to 2022-03-28)
    Posted: 2022-01-07
    Subject matter details: 2
    Government institutions: 7
    Communication techniques: 2
    Government funding: No
  11. Canadian Antimicrobial Innovation Coalition
    Type: Consultant
    Lobbyist: Joanna Carey, Magnet Strategy Group
    Registration: 3 of 5 (2021-12-31 to 2022-12-22)
    Posted: 2021-12-31
    Subject matter details: 2
    Government institutions: 7
    Communication techniques: 2
    Government funding: No
  12. Merck Canada Inc.
    Type: In-house Corporation
    Responsible officer: Marwan Akar, PRESIDENT
    Registration: 41 of 41 (2021-09-17 to present)
    Posted: 2021-10-18
    Subject matter details: 30
    Government institutions: 28
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 9
  13. Merck Canada Inc.
    Type: Consultant
    Lobbyist: Joanna Carey, Magnet Strategy Group
    Registration: 2 of 5 (2021-06-02 to 2022-01-06)
    Posted: 2021-06-03
    Subject matter details: 2
    Government institutions: 7
    Communication techniques: 2
    Government funding: No
  14. Canadian Antimicrobial Innovation Coalition
    Type: Consultant
    Lobbyist: Joanna Carey, Magnet Strategy Group
    Registration: 2 of 5 (2021-05-17 to 2021-12-31)
    Posted: 2021-06-14
    Subject matter details: 2
    Government institutions: 7
    Communication techniques: 2
    Government funding: No
  15. Merck Canada Inc.
    Type: In-house Corporation
    Responsible officer: Anna Van Acker, PRESIDENT AND MANAGING DIRECTOR
    Registration: 40 of 41 (2021-04-29 to 2021-09-17)
    Posted: 2021-05-10
    Subject matter details: 30
    Government institutions: 28
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 10
  16. Merck Canada
    Type: Consultant
    Lobbyist: Fernand Le Fèvre, Teneo
    Registration: 2 of 2 (2021-04-28 to 2021-09-20)
    Posted: 2021-04-28
    Subject matter details: 1
    Government institutions: 3
    Communication techniques: 2
    Government funding: No
  17. Merck Canada Inc.
    Type: In-house Corporation
    Responsible officer: Anna Van Acker, PRESIDENT AND MANAGING DIRECTOR
    Registration: 39 of 41 (2021-04-26 to 2021-04-29)
    Posted: 2021-04-26
    Subject matter details: 30
    Government institutions: 28
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 10
  18. Merck Canada Inc.
    Type: Consultant
    Lobbyist: Joanna Carey, Magnet Strategy Group
    Registration: 1 of 5 (2021-03-30 to 2021-06-02)
    Posted: 2021-03-31
    Subject matter details: 2
    Government institutions: 6
    Communication techniques: 2
    Government funding: No
  19. Canadian Antimicrobial Innovation Coalition
    Type: Consultant
    Lobbyist: Joanna Carey, Magnet Strategy Group
    Registration: 1 of 5 (2021-03-30 to 2021-05-17)
    Posted: 2021-04-01
    Subject matter details: 2
    Government institutions: 6
    Communication techniques: 2
    Government funding: No
  20. Merck Canada
    Type: Consultant
    Lobbyist: Fernand Le Fèvre, Teneo
    Registration: 1 of 2 (2020-11-11 to 2021-04-28)
    Posted: 2020-11-16
    Subject matter details: 1
    Government institutions: 3
    Communication techniques: 2
    Government funding: No
  21. Merck Canada Inc.
    Type: Consultant
    Lobbyist: Danielle Peters, Magnet Strategy Group
    Registration: 6 of 7 (2020-11-05 to 2023-01-02)
    Posted: 2020-11-06
    Subject matter details: 2
    Government institutions: 6
    Communication techniques: 2
    Government funding: No
  22. Canadian Antimicrobial Innovation Coalition
    Type: Consultant
    Lobbyist: Danielle Peters, Magnet Strategy Group
    Registration: 1 of 3 (2020-10-29 to 2022-04-01)
    Posted: 2020-11-09
    Subject matter details: 1
    Government institutions: 6
    Communication techniques: 2
    Government funding: No
  23. Merck Canada
    Type: Consultant
    Lobbyist: Alexandra Dionne Charest, Teneo
    Registration: 1 of 1 (2020-10-09 to 2022-03-10)
    Posted: 2020-10-16
    Subject matter details: 1
    Government institutions: 3
    Communication techniques: 2
    Government funding: No
  24. Merck Canada Inc.
    Type: In-house Corporation
    Responsible officer: Anna Van Acker, PRESIDENT AND MANAGING DIRECTOR
    Registration: 38 of 41 (2020-09-18 to 2021-04-26)
    Posted: 2020-09-18
    Subject matter details: 30
    Government institutions: 28
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 9
  25. Merck Canada Inc.
    Type: In-house Corporation
    Responsible officer: Anna Van Acker, PRESIDENT AND MANAGING DIRECTOR
    Registration: 37 of 41 (2020-09-16 to 2020-09-18)
    Posted: 2020-09-16
    Subject matter details: 30
    Government institutions: 28
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 9
  26. Canadian Biosimilars Forum / Forum canadien des biosimilaires
    Type: Consultant
    Lobbyist: Ross Wallace, Santis Health
    Registration: 5 of 5 (2020-08-05 to 2021-02-16)
    Posted: 2020-08-06
    Subject matter details: 1
    Government institutions: 2
    Communication techniques: 2
    Government funding: No
  27. Merck Canada Inc.
    Type: Consultant
    Lobbyist: Danielle Peters, Magnet Strategy Group
    Registration: 5 of 7 (2020-05-25 to 2020-11-05)
    Posted: 2020-05-25
    Subject matter details: 2
    Government institutions: 6
    Communication techniques: 2
    Government funding: No
  28. Merck Canada
    Type: Consultant
    Lobbyist: Eva Falk Pedersen, TACT - Intelligence conseil
    Registration: 1 of 1 (2020-02-24 to 2020-06-09)
    Posted: 2020-03-03
    Subject matter details: 1
    Government institutions: 4
    Communication techniques: 2
    Government funding: No
  29. Life Saving Therapies Network (LSTN)
    Type: Consultant
    Lobbyist: Jodie Kiss, 3Sixty Public Affairs Inc.
    Registration: 1 of 3 (2020-02-21 to 2020-02-24)
    Posted: 2020-02-24
    Subject matter details: 6
    Government institutions: 7
    Communication techniques: 2
    Government funding: No
  30. Life Saving Therapies Network (LSTN)
    Type: Consultant
    Lobbyist: WILLIAM DEMPSTER, 3Sixty Public Affairs Inc.
    Registration: 1 of 2 (2020-02-20 to 2020-02-20)
    Posted: 2020-02-24
    Subject matter details: 6
    Government institutions: 7
    Communication techniques: 2
    Government funding: No
  31. Merck Canada Inc.
    Type: Consultant
    Lobbyist: Chad Rogers, Crestview Strategy Inc.
    Registration: 1 of 1 (2020-01-31 to 2020-06-30)
    Posted: 2020-02-06
    Subject matter details: 2
    Government institutions: 7
    Communication techniques: 2
    Government funding: No
  32. Merck Canada
    Type: Consultant
    Lobbyist: Julien Nepveu-Villeneuve, TACT Intelligence-Conseil
    Registration: 2 of 2 (2020-01-21 to 2020-04-01)
    Posted: 2020-01-21
    Subject matter details: 1
    Government institutions: 3
    Communication techniques: 2
    Government funding: No
  33. Merck Canada Inc.
    Type: Consultant
    Lobbyist: Patricia Sibal, Crestview Strategy
    Registration: 1 of 1 (2019-08-06 to 2020-12-17)
    Posted: 2019-08-07
    Subject matter details: 2
    Government institutions: 7
    Communication techniques: 2
    Government funding: No
  34. Merck Canada Inc.
    Type: Consultant
    Lobbyist: Susie Heath, Crestview Strategy
    Registration: 1 of 1 (2019-07-02 to 2020-03-06)
    Posted: 2019-07-03
    Subject matter details: 2
    Government institutions: 7
    Communication techniques: 2
    Government funding: No
  35. Merck Canada Inc.
    Type: Consultant
    Lobbyist: Jennifer Babcock, Crestview Strategy
    Registration: 2 of 2 (2019-06-05 to 2019-06-27)
    Posted: 2019-06-26
    Subject matter details: 2
    Government institutions: 7
    Communication techniques: 2
    Government funding: No
  36. Merck Canada
    Type: Consultant
    Lobbyist: Julien Nepveu-Villeneuve, TACT Intelligence-Conseil
    Registration: 1 of 2 (2019-04-26 to 2019-09-01)
    Posted: 2019-05-06
    Subject matter details: 1
    Government institutions: 3
    Communication techniques: 2
    Government funding: No
  37. Canadian Biosimilars Forum / Forum canadien des biosimilaires
    Type: Consultant
    Lobbyist: Ross Wallace, Santis Health
    Registration: 4 of 5 (2019-04-18 to 2020-08-05)
    Posted: 2019-04-24
    Subject matter details: 1
    Government institutions: 2
    Communication techniques: 2
    Government funding: No
  38. Merck Canada Inc.
    Type: Consultant
    Lobbyist: Jennifer Babcock, Crestview Strategy
    Registration: 1 of 2 (2019-03-22 to 2019-06-05)
    Posted: 2019-03-22
    Subject matter details: 2
    Government institutions: 6
    Communication techniques: 2
    Government funding: No
  39. Merck Canada Inc.
    Type: Consultant
    Lobbyist: Danielle Peters, Magnet Strategy Group
    Registration: 4 of 7 (2019-03-20 to 2020-05-25)
    Posted: 2019-03-20
    Subject matter details: 2
    Government institutions: 6
    Communication techniques: 2
    Government funding: No
  40. Merck Canada Inc.
    Type: In-house Corporation
    Responsible officer: Anna Van Acker, PRESIDENT AND MANAGING DIRECTOR
    Registration: 36 of 41 (2019-03-11 to 2020-09-16)
    Posted: 2019-03-13
    Subject matter details: 30
    Government institutions: 29
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 10
  41. Merck Canada Inc.
    Type: Consultant
    Lobbyist: CARL BALTARE, GLOBAL PUBLIC AFFAIRS
    Registration: 9 of 9 (2018-06-25 to 2020-01-14)
    Posted: 2018-06-27
    Subject matter details: 27
    Government institutions: 10
    Communication techniques: 2
    Government funding: No
  42. Merck Canada Inc.
    Type: Consultant
    Lobbyist: Roberta Kramchynsky, Global Public Affairs
    Registration: 8 of 8 (2018-06-25 to 2019-01-25)
    Posted: 2018-06-27
    Subject matter details: 27
    Government institutions: 10
    Communication techniques: 2
    Government funding: No
  43. Merck Canada Inc.
    Type: Consultant
    Lobbyist: Stephen Sampson, Global Public Affairs
    Registration: 8 of 8 (2018-04-25 to 2020-12-31)
    Posted: 2018-04-27
    Subject matter details: 27
    Government institutions: 10
    Communication techniques: 2
    Government funding: No
  44. Merck Canada Inc.
    Type: Consultant
    Lobbyist: Mylène Dupéré, TACT Intelligence-Conseil
    Registration: 1 of 1 (2018-01-16 to 2018-10-04)
    Posted: 2018-01-23
    Subject matter details: 1
    Government institutions: 2
    Communication techniques: 2
    Government funding: No
  45. Merck Canada Inc.
    Type: In-house Corporation
    Responsible officer: Anna Van Acker, PRESIDENT AND MANAGING DIRECTOR
    Registration: 35 of 41 (2017-12-14 to 2019-03-11)
    Posted: 2018-03-22
    Subject matter details: 30
    Government institutions: 29
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 10
  46. Merck Canada Inc.
    Type: Consultant
    Lobbyist: Danielle Peters, Magnet Strategy Group
    Registration: 3 of 7 (2017-11-08 to 2019-03-20)
    Posted: 2018-04-10
    Subject matter details: 1
    Government institutions: 6
    Communication techniques: 2
    Government funding: No
  47. Canadian Biosimilars Forum / Forum canadien des biosimilaires
    Type: Consultant
    Lobbyist: Ross Wallace, Santis Health
    Registration: 3 of 5 (2017-11-02 to 2019-04-18)
    Posted: 2017-11-07
    Subject matter details: 1
    Government institutions: 2
    Communication techniques: 2
    Government funding: No
  48. Merck Canada Inc.
    Type: Consultant
    Lobbyist: Danielle Peters, Magnet Strategy Group
    Registration: 2 of 7 (2017-10-03 to 2017-11-08)
    Posted: 2017-10-23
    Subject matter details: 1
    Government institutions: 6
    Communication techniques: 2
    Government funding: No
  49. Merck Canada Inc.
    Type: In-house Corporation
    Responsible officer: Chirfi Guindo, PRESIDENT
    Registration: 34 of 41 (2017-09-20 to 2017-12-14)
    Posted: 2017-09-21
    Subject matter details: 30
    Government institutions: 29
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 9
  50. Merck Canada Inc.
    Type: In-house Corporation
    Responsible officer: Chirfi Guindo, PRESIDENT
    Registration: 33 of 41 (2017-08-16 to 2017-09-20)
    Posted: 2017-08-16
    Subject matter details: 30
    Government institutions: 29
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 9

Monthly communication reports (232)
Results: 1-50 | Export
  1. Merck Canada Inc.
    Type: In-house Corporation
    Occurred: 2024-02-15
    Posted: 2024-03-13
    Designated public office holders:
    • Rodrigo Arancibia, Director, Life Science Industries Directorate | Innovation, Science and Economic Development Canada (ISED)
    Subject matters:
    • Science and Technology
    • Industry
    • Research and Development
  2. Merck Canada Inc.
    Type: In-house Corporation
    Occurred: 2023-11-08
    Posted: 2023-12-15
    Designated public office holders:
    • Ritu Banerjee, Assistant Deputy Minister, Director General's Office | Innovation, Science and Economic Development Canada (ISED)
    • Simon Kennedy, Office of Deputy Minister | Innovation, Science and Economic Development Canada (ISED)
    Subject matters:
    • Industry
    • Economic Development
    • Health
  3. Merck Canada Inc.
    Type: In-house Corporation
    Occurred: 2023-11-08
    Posted: 2023-12-15
    Designated public office holders:
    • Mohamad Iqbal Ravalia, Honorable Senator | Senate of Canada
    • F. Gigi Osler, Senate of Canada, Hororable Senator | Senate of Canada
    Subject matters:
    • Industry
    • Health
  4. Merck Canada Inc.
    Type: In-house Corporation
    Occurred: 2023-11-07
    Posted: 2023-12-15
    Designated public office holders:
    • sharon burey, Honorable Senator | Senate of Canada
    • Corey Tochor, Member of Parliament | House of Commons
    • Anton Lori, Party Leader | House of Commons
    • Connor MacDonald, Policy Advisor | House of Commons
    • Christopher Evelyn, MInsiter of Families | Employment and Social Development Canada (ESDC)
    Subject matters:
    • Industry
    • Health
  5. Merck Canada Inc.
    Type: In-house Corporation
    Occurred: 2023-11-06
    Posted: 2023-12-15
    Designated public office holders:
    • Stephen Ellis, Member house of Commons | House of Commons
    • Valerie Bradford, Member of Parliament | House of Commons
    • Chandra Arya, Member of House of Commons | House of Commons
    • Yash Nanda, Policy Advisor | Finance Canada (FIN)
    Subject matters:
    • Health
  6. Merck Canada Inc.
    Type: In-house Corporation
    Occurred: 2023-10-11
    Posted: 2023-11-10
    Designated public office holders:
    • Milan Patel, Director, Vaccine Supply & Assurance | Public Health Agency of Canada (PHAC)
    • Michael Pignat, Manager, Procurement | Public Health Agency of Canada (PHAC)
    • David Hennigar, Senior Policy Analyst | Public Health Agency of Canada (PHAC)
    • Alan Thom, Sr Manager, Vaccine Supply and Assurance | Public Health Agency of Canada (PHAC)
    Subject matters:
    • Industry
    • Health
  7. Merck Canada Inc.
    Type: In-house Corporation
    Occurred: 2023-09-22
    Posted: 2023-10-11
    Designated public office holders:
    • Matthew Tunis, Executive Secretary, National Advisory Committee on Immunization | Health Canada (HC)
    Subject matters:
    • Industry
    • Health
  8. Merck Canada Inc.
    Type: In-house Corporation
    Occurred: 2023-09-05
    Posted: 2023-10-11
    Designated public office holders:
    • Ritu Banerjee, Assistant Deputy Minister, Director General's Office | Innovation, Science and Economic Development Canada (ISED)
    • Rodrigo Arancibia, Director, Life Science Industries Directorate | Innovation, Science and Economic Development Canada (ISED)
    Subject matters:
    • Economic Development
    • Research and Development
    • Health
  9. Merck Canada Inc.
    Type: In-house Corporation
    Occurred: 2023-08-03
    Posted: 2023-09-13
    Designated public office holders:
    • Dr. Stephen Ellis, Member of Parliament | House of Commons
    Subject matters:
    • Health
    • Industry
  10. Merck Canada Inc.
    Type: In-house Corporation
    Occurred: 2023-06-06
    Posted: 2023-07-12
    Designated public office holders:
    • ritu Banerjee, Assistant deputy Minister, Life Science & Biomanufacturing Branch | Innovation, Science and Economic Development Canada (ISED)
    • Rodrigo Arancibia, Director, Life Science Industries Directorate | Innovation, Science and Economic Development Canada (ISED)
    Subject matters:
    • Science and Technology
    • Research and Development
    • Industry
  11. Merck Canada Inc.
    Type: In-house Corporation
    Occurred: 2023-04-25
    Posted: 2023-05-15
    Designated public office holders:
    • Robert Kitchen, Member of Parlilament | House of Commons
    Subject matters:
    • Economic Development
    • Intellectual Property
    • Industry
    • Research and Development
    • Health
  12. Merck Canada Inc.
    Type: In-house Corporation
    Occurred: 2023-04-20
    Posted: 2023-05-15
    Designated public office holders:
    • Majid Jowhari, Member of Parliament | House of Commons
    Subject matters:
    • Research and Development
    • Industry
    • Intellectual Property
    • Science and Technology
    • Health
    • Economic Development
  13. Merck Canada Inc.
    Type: In-house Corporation
    Occurred: 2023-03-14
    Posted: 2023-04-11
    Designated public office holders:
    • Matthew Tunis, Executive Secretary, National Advisory Committee on Immunization | Public Health Agency of Canada (PHAC)
    Subject matters:
    • Industry
  14. Merck Canada Inc.
    Type: In-house Corporation
    Occurred: 2022-11-30
    Posted: 2022-12-12
    Designated public office holders:
    • Hilary Peirce, Senior Policy Advisor | Treasury Board Of Canada Secretariat (TBS)
    Subject matters:
    • Research and Development
    • Health
    • Science and Technology
    • Intellectual Property
    • Economic Development
  15. Merck Canada Inc.
    Type: In-house Corporation
    Occurred: 2022-10-27
    Posted: 2022-11-11
    Designated public office holders:
    • Bianca Hossain, Sr Special Assistant | Innovation, Science and Economic Development Canada (ISED)
    Subject matters:
    • Industry
    • Health
    • Science and Technology
    • Economic Development
    • Research and Development
  16. Merck Canada Inc.
    Type: In-house Corporation
    Occurred: 2022-10-19
    Posted: 2022-11-11
    Designated public office holders:
    • david Norris, Acting Deputy Director, Intellectual Property Trade Policy | Global Affairs Canada (GAC)
    Subject matters:
    • Intellectual Property
  17. Merck Canada Inc.
    Type: In-house Corporation
    Occurred: 2022-07-22
    Posted: 2022-08-09
    Designated public office holders:
    • Nancy Hamzawi, Assistant Deputy Minister | Health Canada (HC)
    • Supriya Sharma, Chief Medical Advisor | Health Canada (HC)
    Subject matters:
    • Science and Technology
    • Research and Development
    • Health
  18. Merck Canada Inc.
    Type: In-house Corporation
    Occurred: 2022-07-11
    Posted: 2022-08-09
    Designated public office holders:
    • Supriya Sharma, Chief Medical Advisor | Health Canada (HC)
    • Nancy Hamzawi, Assistant Deputy Minister | Health Canada (HC)
    Subject matters:
    • Health
    • Science and Technology
    • Research and Development
  19. Merck Canada Inc.
    Type: In-house Corporation
    Occurred: 2022-06-24
    Posted: 2022-07-12
    Designated public office holders:
    • samir khan, Sr Advisor for Employment | Employment and Social Development Canada (ESDC)
    • Michelle Boudreau, Executive Director, Office of Pharmaceutical Management Strategies | Health Canada (HC)
    Subject matters:
    • Industry
    • Health
    • Research and Development
    • Science and Technology
  20. Merck Canada Inc.
    Type: In-house Corporation
    Occurred: 2022-06-21
    Posted: 2022-07-12
    Designated public office holders:
    • Sandenga Yeba, Senior Policy Advisor, Minister's Office | Health Canada (HC)
    • Jean-Sebastien Bock, Director of Policy, Office of the Minister of Health | Health Canada (HC)
    Subject matters:
    • Industry
    • Research and Development
    • Health
    • Science and Technology
  21. Merck Canada Inc.
    Type: In-house Corporation
    Occurred: 2022-06-20
    Posted: 2022-07-12
    Designated public office holders:
    • Nancy Hamzawi, Assistant Deputy Minister | Health Canada (HC)
    • Supriya Sharma, Chief Medical Advisor | Health Canada (HC)
    Subject matters:
    • Industry
    • Research and Development
    • Health
    • Science and Technology
  22. Merck Canada Inc.
    Type: In-house Corporation
    Occurred: 2022-06-07
    Posted: 2022-07-12
    Designated public office holders:
    • Supriya Sharma, Chief Medical Advisor | Health Canada (HC)
    • Stephen Lucas, Deputy Minister | Health Canada (HC)
    • Nancy Hamzawi, Assistant Deputy Minister | Health Canada (HC)
    Subject matters:
    • Industry
    • Research and Development
    • Science and Technology
    • Health
  23. Merck Canada Inc.
    Type: In-house Corporation
    Occurred: 2022-06-03
    Posted: 2022-07-12
    Designated public office holders:
    • Jamie Kippen, Chief of Staff, Minister's Office | Health Canada (HC)
    Subject matters:
    • Health
    • Research and Development
    • Industry
    • Science and Technology
  24. Merck Canada Inc.
    Type: In-house Corporation
    Occurred: 2022-05-19
    Posted: 2022-06-13
    Designated public office holders:
    • Rodrigo Arancibia, Director, Life Science Industries Directorate | Innovation, Science and Economic Development Canada (ISED)
    Subject matters:
    • Health
    • Economic Development
    • Research and Development
    • Science and Technology
    • Industry
  25. Merck Canada Inc.
    Type: In-house Corporation
    Occurred: 2022-05-05
    Posted: 2022-06-13
    Designated public office holders:
    • Stephen Lucas, Deputy Minister | Health Canada (HC)
    • Nancy Hamzawi, Assistant Deputy Minister | Health Canada (HC)
    • Supriya Sharma, Chief Medical Advisor | Health Canada (HC)
    Subject matters:
    • Industry
    • Research and Development
    • Science and Technology
    • Health
  26. Merck Canada Inc.
    Type: In-house Corporation
    Occurred: 2022-04-25
    Posted: 2022-05-16
    Designated public office holders:
    • michelle Mujoomdar, Dir Office of Pharmaceutical Mgmt/Strategy | Health Canada (HC)
    Subject matters:
    • Industry
    • Science and Technology
    • Health
    • Research and Development
  27. Merck Canada Inc.
    Type: In-house Corporation
    Occurred: 2022-04-05
    Posted: 2022-05-16
    Designated public office holders:
    • Jamie Kippen, Chief of Staff, Minister's Office | Health Canada (HC)
    Subject matters:
    • Industry
    • Health
    • Research and Development
    • Science and Technology
  28. Merck Canada Inc.
    Type: In-house Corporation
    Occurred: 2022-03-31
    Posted: 2022-04-14
    Designated public office holders:
    • Yash Nanda, Policy Advisor, Minister of Finance | House of Commons
    Subject matters:
    • Health
  29. Merck Canada Inc.
    Type: In-house Corporation
    Occurred: 2022-03-28
    Posted: 2022-04-14
    Designated public office holders:
    • Jamie Kippen, Chief of Staff, Minister's Office | Health Canada (HC)
    Subject matters:
    • Industry
    • Research and Development
    • Science and Technology
  30. Merck Canada Inc.
    Type: In-house Corporation
    Occurred: 2022-03-23
    Posted: 2022-04-14
    Designated public office holders:
    • Maria Campbell, Minister Exempt Staff, Office of the Minister of Seniors | Employment and Social Development Canada (ESDC)
    Subject matters:
    • Health
  31. Merck Canada Inc.
    Type: Consultant
    Lobbyist: Joanna Carey, Magnet Strategy Group
    Occurred: 2022-03-23
    Posted: 2022-04-16
    Designated public office holders:
    • Maria Campbell, Policy Advisor, Office of the Minister of Seniors | Employment and Social Development Canada (ESDC)
    Subject matters:
    • Health
  32. Merck Canada Inc.
    Type: In-house Corporation
    Occurred: 2022-03-22
    Posted: 2022-04-14
    Designated public office holders:
    • Darryl patterson, Director General | Innovation, Science and Economic Development Canada (ISED)
    • Rodrigo Arancibia, Director, Life Science Industries Directorate | Innovation, Science and Economic Development Canada (ISED)
    Subject matters:
    • Industry
    • Research and Development
    • Science and Technology
    • Health
    • Economic Development
  33. Merck Canada Inc.
    Type: In-house Corporation
    Occurred: 2022-03-21
    Posted: 2022-04-14
    Designated public office holders:
    • Jamie Kippen, Chief of Staff, Minister's Office | Health Canada (HC)
    Subject matters:
    • Health
    • Research and Development
    • Industry
    • Science and Technology
  34. Merck Canada Inc.
    Type: In-house Corporation
    Occurred: 2022-03-16
    Posted: 2022-04-14
    Designated public office holders:
    • Michelle Boudreau, Executive Director, Strategic Policy Branch | Health Canada (HC)
    Subject matters:
    • Industry
  35. Merck Canada Inc.
    Type: In-house Corporation
    Occurred: 2022-03-03
    Posted: 2022-04-14
    Designated public office holders:
    • Nancy Hamzawi, Assistant Deputy Minister | Health Canada (HC)
    • Stephen Lucas, Deputy Minister | Health Canada (HC)
    Subject matters:
    • Industry
    • Science and Technology
    • Health
    • Research and Development
  36. Merck Canada Inc.
    Type: In-house Corporation
    Occurred: 2022-03-02
    Posted: 2022-04-14
    Designated public office holders:
    • Rodrigo Arancibia, Director, Life Science Industries Directorate | Innovation, Science and Economic Development Canada (ISED)
    Subject matters:
    • Economic Development
    • Industry
    • Science and Technology
    • Health
    • Research and Development
  37. Merck Canada Inc.
    Type: In-house Corporation
    Occurred: 2022-02-24
    Posted: 2022-03-11
    Designated public office holders:
    • Isa Topbas, Special Assistant | Innovation, Science and Economic Development Canada (ISED)
    Subject matters:
    • Science and Technology
    • Research and Development
    • Health
    • Economic Development
    • Industry
  38. Merck Canada Inc.
    Type: In-house Corporation
    Occurred: 2022-02-22
    Posted: 2022-03-11
    Designated public office holders:
    • Rodrigo Arancibia, Director, Life Science Industries Directorate | Innovation, Science and Economic Development Canada (ISED)
    Subject matters:
    • Industry
    • Science and Technology
    • Economic Development
    • Research and Development
    • Health
  39. Merck Canada
    Type: Consultant
    Lobbyist: Alexandra Dionne Charest, Teneo
    Occurred: 2022-02-17
    Posted: 2022-03-10
    Designated public office holders:
    • Luc Thériault, Member of Parliament, Bloc Québécois | House of Commons
    Subject matters:
    • Economic Development
    • Health
    • Research and Development
  40. Merck Canada Inc.
    Type: In-house Corporation
    Occurred: 2022-02-07
    Posted: 2022-03-11
    Designated public office holders:
    • Isa Topbas, Special Assistant | Innovation, Science and Economic Development Canada (ISED)
    Subject matters:
    • Industry
    • Research and Development
    • Science and Technology
    • Health
  41. Merck Canada Inc.
    Type: In-house Corporation
    Occurred: 2022-02-07
    Posted: 2022-03-11
    Designated public office holders:
    • Rodrigo Arancibia, Director, Life Science Industries Directorate | Innovation, Science and Economic Development Canada (ISED)
    Subject matters:
    • Science and Technology
    • Health
    • Research and Development
    • Industry
    • Economic Development
  42. Merck Canada Inc.
    Type: In-house Corporation
    Occurred: 2022-02-03
    Posted: 2022-03-11
    Designated public office holders:
    • Mary-Rose Brown, Senior Policy Advisor, Minister's Office | Finance Canada (FIN)
    Subject matters:
    • Economic Development
  43. Merck Canada
    Type: Consultant
    Lobbyist: Alexandra Dionne Charest, Teneo
    Occurred: 2022-01-31
    Posted: 2022-02-15
    Designated public office holders:
    • Luc Berthold , Member of Parliament, Conservative Party | House of Commons
    Subject matters:
    • Research and Development
    • Health
    • Economic Development
  44. Merck Canada Inc.
    Type: In-house Corporation
    Occurred: 2022-01-28
    Posted: 2022-02-08
    Designated public office holders:
    • jacqueline Arthur, Executive Director | Public Health Agency of Canada (PHAC)
    Subject matters:
    • Health
    • Industry
  45. Merck Canada Inc.
    Type: In-house Corporation
    Occurred: 2022-01-24
    Posted: 2022-02-08
    Designated public office holders:
    • Stephen Lucas, Deputy Minister | Health Canada (HC)
    Subject matters:
    • Industry
    • Health
  46. Merck Canada Inc.
    Type: In-house Corporation
    Occurred: 2022-01-18
    Posted: 2022-02-08
    Designated public office holders:
    • Supriya Sharma, Chief Medical Advisor | Health Canada (HC)
    Subject matters:
    • Industry
    • Health
  47. Merck Canada Inc.
    Type: In-house Corporation
    Occurred: 2021-12-17
    Posted: 2022-01-12
    Designated public office holders:
    • Kirsty Duncan, Member of Parliament | House of Commons
    Subject matters:
    • Health
    • Industry
  48. Merck Canada Inc.
    Type: In-house Corporation
    Occurred: 2021-12-16
    Posted: 2022-01-12
    Designated public office holders:
    • Michelle Boudreau, Executive Director, Strategic Policy Branch | Health Canada (HC)
    Subject matters:
    • Industry
  49. Merck Canada Inc.
    Type: In-house Corporation
    Occurred: 2021-12-09
    Posted: 2022-01-12
    Designated public office holders:
    • Isa Topbas, Regional Director Advisor Ontario & Atlantic, Office of Minister of Innovation | Innovation, Science and Economic Development Canada (ISED)
    Subject matters:
    • Industry
    • Health
  50. Merck Canada Inc.
    Type: In-house Corporation
    Occurred: 2021-11-27
    Posted: 2021-12-15
    Designated public office holders:
    • Sarah Hussaini, Chief of Staff | Innovation, Science and Economic Development Canada (ISED)
    Subject matters:
    • Industry
    • Health

Date Modified: